Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0045
Source ID: NCT04702997
Associated Drug: Bardoxolone Methyl Oral Capsule
Title: A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
Acronym: MERLIN
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT04702997/results
Conditions: Chronic Kidney Diseases
Interventions: DRUG: Bardoxolone methyl oral capsule|DRUG: Placebo oral capsule
Outcome Measures: Primary: Change From Baseline in Estimated Glomerular Filtration Rate (eGFR) at Week 12, To assess the change in eGFR from baseline to week 12. eGFR is a measure of kidney function assessed through blood/serum. Higher eGFRs represent better/improved kidney function. Lower eGFRs represent poorer/decreased kidney function., Baseline through 12 weeks after participant receives the first dose |
Sponsor/Collaborators: Sponsor: Reata, a wholly owned subsidiary of Biogen
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 81
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2021-02-09
Completion Date: 2021-11-23
Results First Posted: 2022-12-01
Last Update Posted: 2024-02-05
Locations: California Institute of Renal Research, La Mesa, California, 91942, United States|Western Nephrology, Arvada, Colorado, 80002, United States|Colorado Kidney Care, Denver, Colorado, 80230, United States|Boise Kidney & Hypertension, PLLC, Nampa, Idaho, 83687, United States|Renal Associates of Baton Rouge, Baton Rouge, Louisiana, 70808, United States|Nephrology Center, PC, Kalamazoo, Michigan, 49007, United States|DaVita Clinical Research, Las Vegas, Nevada, 89128, United States|Columbia Nephrology Associates, PA, Columbia, South Carolina, 29203, United States|Renal Disease Research Intitute, Dallas, Texas, 75235, United States|DaVita Clinical Research, Houston, Texas, 77004, United States|Gamma Medical Research Inc, McAllen, Texas, 78503, United States|Clinical Advancement Center, PLLC, San Antonio, Texas, 78212, United States
URL: https://clinicaltrials.gov/show/NCT04702997